Cite
Extracellular vesicles derived from Plasmodium-infected and non-infected red blood cells as targeted drug delivery vehicles.
MLA
Borgheti-Cardoso, Livia Neves, et al. “Extracellular Vesicles Derived from Plasmodium-Infected and Non-Infected Red Blood Cells as Targeted Drug Delivery Vehicles.” International Journal of Pharmaceutics, vol. 587, Sept. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2020.119627.
APA
Borgheti-Cardoso, L. N., Kooijmans, S. A. A., Chamorro, L. G., Biosca, A., Lantero, E., Ramírez, M., Avalos-Padilla, Y., Crespo, I., Fernández, I., Fernandez-Becerra, C., del Portillo, H. A., & Fernàndez-Busquets, X. (2020). Extracellular vesicles derived from Plasmodium-infected and non-infected red blood cells as targeted drug delivery vehicles. International Journal of Pharmaceutics, 587, N.PAG. https://doi.org/10.1016/j.ijpharm.2020.119627
Chicago
Borgheti-Cardoso, Livia Neves, Sander A.A. Kooijmans, Lucía Gutiérrez Chamorro, Arnau Biosca, Elena Lantero, Miriam Ramírez, Yunuen Avalos-Padilla, et al. 2020. “Extracellular Vesicles Derived from Plasmodium-Infected and Non-Infected Red Blood Cells as Targeted Drug Delivery Vehicles.” International Journal of Pharmaceutics 587 (September): N.PAG. doi:10.1016/j.ijpharm.2020.119627.